Researchers across Nova Scotia are launching a project aimed at detecting the presence of the virus that causes COVID-19 in human wastewater, helping to identify the potential presence of... Read More
Like many companies, when we launched our strategic plan in January, we had no idea what the year would hold. We will remember 2020 not only as a year... Read More
Vancouver, B.C. – Dec. 14, 2020 – Biotechnology leader LuminUltra has partnered with BuiltSpace, a building data and asset tracking specialist, and scientists at the University of British Columbia... Read More
LuminUltra’s point-of-need and high-volume testing solutions capable of serving a range of COVID testing needs in under two hours FREDERICTON, NB, December 3, 2020 – Biotechnology front-runner LuminUltra is... Read More
FREDERICTON, NB, November 30, 2020 – Biotechnology front-runner LuminUltra today announced the acquisition of Source Molecular Corporation, a leader in lab-based testing solutions for microbial source tracking of pathogens... Read More
Partnership brings together leaders in their respective fields to advocate for an innovative, science-based approach to pandemic management CANADA – Nov. 18, 2020 – Biotechnology leader LuminUltra has partnered with The Infection Prevention Strategy (TIPS) in the fight against COVID-19 to provide... Read More
LuminUltra has filed a patent for the first complete, rapid, and on-site COVID-19 wastewater testing solution that will make non-invasive community health assessment far more accessible to both the... Read More
The GeneCount® COVID-19 RT-qPCR Assay Kit has been submitted to the U.S. FDA for Emergency Use Authorization and to Health Canada for an Interim Order.... Read More
Atlantic Business Magazine has named LuminUltra Technologies Ltd.'s Chairman & CEO, Pat Whalen, to their 2020 Top 50 CEO list. Read the full story here.... Read More
NGen has announced $3.5 million in project funding in support of Canada’s COVID-19 response, which includes support for LuminUltra's scale-up.... Read More